How to manage bleeding from a hemangioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hemangioma Bleeding

For bleeding hemangiomas, apply direct pressure followed by topical tranexamic acid to control bleeding, while considering oral propranolol as the definitive treatment for the underlying hemangioma. 1

Initial Management of Active Bleeding

  1. Direct pressure control:

    • Apply firm, continuous pressure with sterile gauze for at least 10-15 minutes
    • For persistent bleeding, maintain pressure for longer periods
  2. Topical hemostatic agents:

    • Apply topical tranexamic acid directly to the bleeding site 1
    • Tranexamic acid works by stabilizing blood clots and has proven effective in controlling hemangioma bleeding
    • For preparation: Use tranexamic acid solution (100 mg/mL) applied directly to the bleeding site
  3. Wound care for ulcerated hemangiomas:

    • Clean with mild antiseptic solution
    • Apply non-adherent dressing
    • Consider petroleum jelly-impregnated gauze to prevent adherence to the wound 2

Definitive Management

After controlling acute bleeding, address the underlying hemangioma:

  1. Pharmacological intervention:

    • First-line therapy: Oral propranolol at 2-3 mg/kg/day divided into 2-3 doses 2, 3
    • Begin treatment as soon as possible, especially for high-risk hemangiomas
    • Continue for at least 6 months to prevent recurrence
  2. Alternative treatments (if propranolol is contraindicated):

    • Oral corticosteroids: Prednisolone or prednisone at 2-3 mg/kg/day as a single morning dose 2
    • Intralesional steroid injections for small, localized hemangiomas 2
    • Topical timolol 0.5% gel for superficial hemangiomas 2, 3

Special Considerations Based on Hemangioma Type

  1. Ulcerated hemangiomas:

    • Most bleeding occurs in ulcerated lesions 2
    • Higher risk locations: scalp, neck, perioral, perineal/perianal regions 2
    • Monitor closely during the proliferative phase (first 4 months of life) 2
  2. Segmental hemangiomas:

    • Higher risk of complications including ulceration and bleeding 2
    • May require more aggressive intervention
    • Consider early referral to specialist
  3. Scalp hemangiomas:

    • Prone to more profuse bleeding when ulcerated 2
    • May require more aggressive management

When to Refer for Advanced Intervention

Refer immediately if:

  • Bleeding cannot be controlled with pressure and topical measures
  • Signs of hemodynamic instability (tachycardia, hypotension)
  • Significant drop in hemoglobin levels
  • Hemangioma in critical locations (periorbital, airway)

Prevention of Recurrent Bleeding

  1. Identify crusting as a warning sign:

    • The presence of crusting, even without frank ulceration, can precede serious bleeding 1
    • Monitor hemangiomas with crusting more closely
  2. Prophylactic treatment:

    • Consider early intervention with propranolol for high-risk hemangiomas before bleeding occurs
    • Protect hemangiomas in vulnerable locations from trauma

Common Pitfalls to Avoid

  1. Underestimating bleeding risk:

    • Although most hemangioma bleeding is minor, scalp hemangiomas and deeply ulcerated lesions can cause significant blood loss 2
  2. Delayed intervention:

    • Waiting too long to initiate treatment for high-risk hemangiomas can lead to preventable complications 3
  3. Inappropriate use of laser therapy:

    • Laser therapy is not first-line for acute bleeding control
    • May be considered for residual telangiectasia after involution 4

By following this approach, most hemangioma bleeding can be effectively controlled while addressing the underlying vascular lesion to prevent recurrence.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Infantile Hemangiomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Guidelines of care for cutaneous haemangiomas.

Annals of the Academy of Medicine, Singapore, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.